Immunova Therapeutics
Blood & Organ Banks · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7707 Fannin St Ste 200, Houston, Texas, ...Phone Number
(832) 491-0069Website
www.immunovatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
2
2
2
1
About Immunova Therapeutics
Immunova Therapeutics specializes in cancer immunotherapy, offering advanced treatments such as CAR-T and TCR-T therapies, as well as antibody and vaccine solutions. Their CAR-T cells are engineered to target specific antigens on cancer cells, while TCR-T therapies focus on intracellular tumor antigens. The company aims to personalize medicine for patients with hematologic malignancies and other cancers. Their innovative approaches are designed to enhance the effectiveness of cancer treatments and improve patient outcomes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunova Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Immunova Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Immunova Therapeutics is spiking on competitors!
Check if Immunova Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Immunova Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Immunova Therapeutics
Product Launch: Get notified when Immunova Therapeutics launches new products
Immunova Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Immunova Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Immunova Therapeutics
Compare insights from companies similar to Immunova Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immunova Therapeutics
<$5M
1-10
Private
-
2012
N/A
Company Profile Activity
Activity Insights
Immunova Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Immunova Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Immunova Therapeutics.
Immunova Therapeutics Tech Stack
A closer look at the technologies used by Immunova Therapeutics
See more technologies
Immunova Therapeutics News & Media
China Focus@ Europe Hamburg Opening a New Chapter In Cooperation...
China Focus, organized by MyBioGate, is a series of partnering forums which launched in 2018. (PRWeb November 20, 2019) Read the full story at https://www.prweb.com/releases/china_focus_europe_hamburg_opening_a_new_chapter_in_cooperation_between_china_and_europe_healthcare_industry/prweb16737271.htm
Read more news
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunova Therapeutics
Sign Up For FreeTo access detailed company insights
Immunova Therapeutics specializes in cancer immunotherapy, offering advanced treatments such as CAR-T and TCR-T therapies, as well as antibody and vaccine solutions. Their CAR-T cells are engineered to target specific antigens on cancer cells, while TCR-T therapies focus on intracellular tumor antigens. The company aims to personalize medicine for... Read More
